|Articles|October 28, 2022
E. coli Plasmid DNA Production in Small Bioreactor
Author(s)Eppendorf
In the biopharmaceutical industry, upstream processing for plasmid DNA production is usually optimized at small scale. We demonstrate the feasibility of using the DASbox® Mini Bioreactor System for process development.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
Mastering Phase-Appropriate Characterization for Biologics Approval
2
From Lab to Patient: The Critical Role of Supply Chain & Distribution in the Life Sciences
3
Maximizing Productivity and Scalability with Perfusion Technology
4
Master Analytical Testing for Biologics Products
5
